Evidence map›Paper›PMID 36376773›Full record

ArticleActa neurologica Belgica2023

Alzheimer disease's cerebrospinal fluid biomarkers differences between immigrants and natives in a Belgian memory clinic.

Louisien Lebrun, Bernard Hanseeuw, Vincent van Pesch, Adrian Ivanoiu

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Acta neurologica Belgica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Louisien LebrunInstitute of NeuroScience (IoNS), UCLouvain, Avenue Mounier 53 B1.53.04, Woluwe-Saint-Lambert, 1200, Brussels, Belgium. louisien.lebrun@uclouvain.be.ORCID http://orcid.org/0000-0002-2459-0354
Bernard HanseeuwInstitute of NeuroScience (IoNS), UCLouvain, Avenue Mounier 53 B1.53.04, Woluwe-Saint-Lambert, 1200, Brussels, Belgium.
Vincent van PeschInstitute of NeuroScience (IoNS), UCLouvain, Avenue Mounier 53 B1.53.04, Woluwe-Saint-Lambert, 1200, Brussels, Belgium.
Adrian IvanoiuInstitute of NeuroScience (IoNS), UCLouvain, Avenue Mounier 53 B1.53.04, Woluwe-Saint-Lambert, 1200, Brussels, Belgium.
Cliniques Universitaires Saint-Luc · BE

Funding

Fonds De La Recherche Scientifique - FNRS 40000041
6 · The paper itself

Abstract

backgroundDiagnosis of neurodegenerative diseases can raise difficulties among immigrant patients due to language, educational or sociocultural differences with natives. CSF biomarkers of Alzheimer's disease are useful tools to early diagnose neurodegeneration. Yet very few studies have investigated differences of those biomarkers between immigrant and native populations.

objectiveWe aimed to characterize differences between CSF biomarkers of Alzheimer's disease within Belgian native and immigrant patients analyzed at Saint Luc Neurochemistry Lab (Brussels, Belgium).

methodsCSF samples from patients consulting at Saint Luc Memory Clinic (n = 356) or at others hospitals (n = 2430) were analyzed by Saint Luc Neurochemistry Lab between 2010 and 2014. We conducted linear regressions predicting CSF biomarkers with demographic data: age, sex and presumed ethnic origin. For the last one, we subdivided the cohort in natives and immigrants according to their surnames.

resultsImmigrant patients benefit from a CSF sample analysis at a younger age than natives (p < 0.001). After linear regressions, age showed a significant impact on all biomarkers (p < 0.005). Ethnicity showed a significant impact on T-Tau (p = 0.007) and on T-Tau/amyloid-β42 ratio (p = 0.009). Sex showed a significant impact on T-Tau (p = 0.002). ANCOVA analysis suggested that the effect of Age on Aβ

conclusionThis study shows higher T-Tau and T-Tau/amyloid-β42 ratio values in younger native patients from a Belgian Memory Clinic. Aβ

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesBelgiumBiomarkersHumanstau ProteinsAmyloid beta-PeptidesBiomarkerstau ProteinsAlzheimer’s diseaseBiomarkersCerebrospinal fluidEthnicity

Identifiers

PMID36376773
OpenAlexW4309029205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.